Answers are grounded in this paper and cite their sources.
Background: Tranexamic acid (TXA) is widely used in orthopedic surgery to mitigate intraoperative and post-operative bleeding. Current literature supports its use in arthroscopic rotator cuff repair (RCR) to increase visualization, decrease operative time, and improve immediate post-operative pain. This study aimed to assess post-operative outcomes of arthroscopic RCR with and without perioperative TXA. We hypothesize that TXA use will result in decreased post-operative complications, including less pain and therefore fewer opioid prescriptions. Methods: < .05 for all analyses. No significant differences were found in pulmonary embolism rates or superficial and deep surgical site infections. Conclusion: This is the first large-scale, database study demonstrating perioperative TXA in the setting of arthroscopic RCR was associated with significantly improved post-operative outcomes, particularly fewer post-operative opioid prescriptions at 30 days and 1 year and a decrease in hospital admissions at 1-year follow-up. This updates the limited current literature surrounding TXA use during shoulder arthroscopy, with some studies suggesting improved visual field and decreased immediate post-operative pain, while others positing no clinical difference in pain reduction. Future well-designed prospective studies are needed to elucidate these associations more fully.
No takes yet. Share an insight, caveat, or question.
Coombs et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: